1Sobel BE. Optimizing cardiovascular outcomes in diabetes mellitus. Am J Med,2007,120(9 Suppl 2):S3-11.
2Chazova TE, Masenko VP, Zykov KA, et al, The role of inflammation factors in development of acute coronary syndrome in patients with type 2 diabetes mellitus and impaired glucose tolerance. Ter Arkh,2007,79: 60-64.
6Corrado E, Novo S. High sensitivity of C-reactive protein in primary prevention. G Ital Cardiol ( Rome), 2007,8:327-334.
7Ford E S. Body mass index,diabetes,and c - creactive proteion among US adults, diabetes Care, 1999,22 : 1971-1977.
8Barzilay J l,Abraham L,Heckbert S R,et al. The relation of markers of inflammation to the development of glucose disorders in the elderly:the cardiovascular health study. Diabetes,2001,50:2384-2389.
9Omoigui S. The Interleukin-6 inflammation pathway from cholesterol to aging-role of statins, bisphosphonates and plant polyphenols in aging anti age-related diseases, Immun Ageing,2007,4:1.
10Sbarsi I, Falcone C, Boiocchi C,et al. Inflammation and atherosclerosis : the role of TNF and TNF receptors polymorphisms in coronary artery disease. Int J Immunopathol Pharmacol, 2007,20 : 145-154.
二级参考文献1
1Mulvihill NT, Foley JB. Inflammation in acute coronary syndromes.Heart,2002,87:201-204.
8Cakmak M, Cakmak N, Cettemen S, et al. The value of admission glycosycoslated hemoglobin level in patients with acute myocaedial infarctiong [J]. Can J cardiol, 2008, 24: 375-378.
9Kosiborod M, Inzucchi SE,Krumholz HM, et al.Glucometrics in pa- tients hospitalized with acute myocardial infarction:defining the op- timal outcomes-based measure of risk [J]. Circulation, 2008, 117: 1018-1027.
10Sirmaeve PR, Steg PG, Fox KA, et al. GRACE Investigators. Asso- ciation of elevated fasting glucose with increased short-term and 6-month mortality in ST-segment elevationg and non-ST-segment el- evation acute coronary syndromes: the Global Registry of Acute Coronary Events [J]. Arch Intern MED, 2009, 169: 402-409.
